Adelyn Cheong
CEO, PVH AmericasPVH
General ManagementView Profile →Chairman, President, and Chief Executive Officer · Labcorp Holdings
Adam Schechter is Chairman, President and Chief Executive Officer of Labcorp. He became CEO after serving on its board and previously led Merck’s global pharmaceutical and vaccine business.
Last reviewed: Oct 30, 2026
Chairman, President, and Chief Executive Officer
Labcorp Holdings
Last Reviewed: October 30, 2026
Adam Schechter is Chairman, President and Chief Executive Officer of Labcorp. He became CEO after serving on its board and previously led Merck’s global pharmaceutical and vaccine business.
Schechter held a range of commercial and leadership positions at Merck before joining Labcorp’s executive team. His responsibilities spanned sales, marketing, managed markets, product development and business development in the United States and globally.
From 2007 to 2010, he served as president of Merck’s global pharmaceutical business. He then became executive vice president and president of Global Human Health, leading the company’s worldwide pharmaceutical and vaccine businesses and serving on its executive committee through 2018.
Schechter joined Labcorp’s board in 2013 and became lead independent director in January 2019. In November 2019, he moved from board oversight into the company’s chief executive role. He became chairman in May 2020.
His subsequent governance work has included joining DaVita’s board in 2022 and Project HOPE’s board in 2025. Those assignments accompany his leadership of Labcorp’s diagnostic and biopharma laboratory businesses.
Schechter earned a Bachelor of Science in Biology from La Salle University. The university also awarded him an honorary Doctor of Humane Letters, which is separate from his earned undergraduate degree.